Loren Data's SAM Daily™

FBO DAILY - FEDBIZOPPS ISSUE OF SEPTEMBER 08, 2016 FBO #5403
DOCUMENT

Q -- Urine Drug Screening - Attachment

Notice Date

9/6/2016
 

Notice Type

Attachment
 

NAICS

621999 — All Other Miscellaneous Ambulatory Health Care Services
 

Contracting Office

Department of Veterans Affairs;VISN 7 Network Contracting Activity;501 Greene Street;Hatcher Building - Suite 2;Augusta GA 30901
 

ZIP Code

30901
 

Solicitation Number

VA24716Q0676
 

Response Due

9/13/2016
 

Archive Date

12/21/2016
 

Point of Contact

Shirley Adams
 

E-Mail Address

3-0188
 

Small Business Set-Aside

Service-Disabled Veteran-Owned Small Business
 

Description

THIS IS A SMALL BUSINESS SOURCES SOUGHT NOTICE REPRESENTING A MARKET SURVEY AND IS NOT A REQUEST FOR PROPOSALS, PROPOSAL ABSTRACTS, QUOTATIONS OR INVITATION FOR BIDS The Department of Veterans Affairs, Augusta GA, is conducting a MARKET SURVEY to obtain information regarding: (1) the availability and capability of qualified small business sources; (2) whether they are Service-Disabled Veteran-Owned (SDVOSB) or Veteran-Owned Small Business (VOSB), concerns; and (3) their size classification relative to the North American Industry Classification System (NAICS) code for the proposed acquisition. Your responses to the information requested will assist the Government in determining the appropriate acquisition method, including whether a set-aside is possible. An organization that is not considered a Services Disabled Veteran Owned Small Business or a Veteran Owned Small Business under the applicable NAICS code should not submit a response to this notice. SDVOSB or VOSB business concerns should be capable of furnishing all labor, supervision, and parts, to include all equipment necessary to perform all work required under the proposed contract. LOCATION: The Columbia VA Medical Center, Columbia SC, requires urine drug screening (UDS) laboratory services and processors for the Dorn VA Medical Columbia SC and surrounding Community Based Outpatient Clinics (CBOCs). A stock of ten (10) portable cylinders, regulators and 02 carriers shall be continuously maintained by the contractor at the VA Medical Centers located in Charleston SC and Dublin GA. These cylinders shall be used to accommodate home oxygen beneficiaries who are visiting the VA or being discharged and require a tank of oxygen to go home. This service shall be provided at no additional cost to the Government. The VA shall furnish storage space and maintain all security for this equipment. The Contractor shall be permitted access to the space and equipment when requested by telephone with 24 hours' notice to the VA Medical Center's prosthetics Service. Contractor shall maintain an updated inventory of all equipment on a quarterly basis. Provide Urine Drug Screen (UDS) laboratory services and processors, also known as contracted lab technicians, to station 544 Dorn VA Medical Center and the Community-Based Outpatient Clinics (CBOCs). It is the intent of the Dorn VA Medical Center to consolidate the Urine Drug Screen (UDS) testing with confirmation to one (1) contractor and decrease the possibility clinical decisions made in error. Currently, the UDS testing is being conducted at numerous outside reference laboratories. This contract will ensure Dorn VA Medical Center is in compliance with all initiatives, directives and policies concerning Opioid Pain Care and will enhance the safe and effective prescribing of opioids to chronic pain patients. 2. PLACE OF PERFORMANCE: Dorn VA Medical Center and Community-Based Outpatient Clinics (CBOCs), Columbia, SC 29209 WJB Dorn VA Medical Center, 6439 Garners Ferry Road, Columbia, SC 29209 CBOC, 1822 Sally Hill Farms Blvd, Florence, SC 29501 CBOC, 407 North Salem Ave., Sumter, SC 29150 CBOC, 1767 Village Park Drive, Orangeburg, SC 29118 CBOC, 1702 East Greenville Street, Anderson, SC 29621 CBOC, 279 North Grove Medical Park Drive, Spartanburg, SC 29303 CBOC, 2670 Mills Park Drive, Rock Hill, SC 29732 CBOC, 41 Park Creek Drive, Greenville, SC 29605 NAICS: 621999 PICKUP AND TRANSPORTATION OF SAMPLES: The contractor shall be responsible for the pick-up and transportation of specimens to the contractor's laboratory(ies). Contractor shall transport samples in such a manner as to ensure the integrity of the specimen. TEST RESULTS: Contractor shall conduct pre-analysis/analysis of samples, providing test results using methodologies with nationally accepted standards of operation. Contractor shall consult with Dorn VA Medical Center or CBOC regarding test results by telephone/fax/Internet Portal as needed. Immediately notify Dorn VA Medical Center or CBOC responsible individual(s) via Internet Portal, telephone, or fax (in order) of an unacceptable specimen. Provide detailed information that warrants classification of unacceptable. The transmission of all test results (partial and complete) shall arrive at the designated location within the VAMC within the required TAT stated in this contract. Repeat Testing for Confirmation of Test Results. The contractor shall provide all repeat testing, upon the request of the ordering facility, at no additional charge to the government. REPORTS: A report is defined as a result downloaded by the contractor into the designated VAMC VISTA database through Electronic Data Interface or made available via internet portal and printed locally. If results are telephoned prior to the downloaded report, the report shall include the name of the individual at the VAMC notified of the results, the date and time of notification, and the name of the individual at the Contractor's laboratory who reported the result(s) via telephone. Reports of routine test results shall be downloaded into VistA or made available via internet portal (and printed locally) in the appropriate Using Service of the VAMC within 24-72 hours or 3 business days following specimen pickup. The Contracting Officer recognizes that certain specialized or esoteric test procedures shall require a TAT greater than 24-72 hours or 3 business days. The Contractor is required to provide a list of those tests that routinely have a TAT in excess of 24-72 hours and also provide results for those tests via downloading results into VISTA with four (4) hours of completing the results for those tests. Immediate response values shall be reported by telephone to the Dorn VA Medical Center technical laboratory personnel to include Medical Laboratory Technicians, Medical Technologists, Section Supervisors, and Laboratory Manager/Chief Medical Technologists immediately following verification of the test results by the Contractor or subcontracted laboratories. The immediate response values shall also be downloaded into VistA at the location designated by the Contracting Officer. Test reports shall include documentation of the person notified at the VAMC about the immediate response value, the date and time of notification, and the name of the person at the Contractor's laboratory who notified personnel at the VAMC. In the event that the Contractor performs overflow tests due to instrument downtime at the VAMC, the Contractor shall have a mechanism of notifying appropriate personnel at the VAMC of immediate response values established for use at the VAMC. Contractor patient reports will provide patient-specific UDS results with comparisons that clearly show if the controlled substance prescribed is the controlled substance that was detected, in addition to specimen validity. Specimen validity will, at a minimum, include temperature (at time of UDS collection), pH, urine creatinine and the presence of oxidizing/masking agents that may, or may not, have been used in patient's attempt to hide/mask illicit drugs or non-prescribed opioids. Contractor patient reports will NOT include any information that does not belong exclusively to the patient being test. This includes any potentially misleading text, diagram or pictures that are meant to compare patient drug levels to the mean or median drug levels of a group of people prescribed the same controlled substances. Absolutely no information that suggests it is possible to correlate a drug level to a patient-specific opioid regimen, even if it is intended by contractor to be for educational or statistical purposes. ANALYZE SAMPLES. The Reference Laboratory will comply with reporting test results with the specified time frame in accordance with the nature of the testing, following all regulatory requirements for reporting of patient results. Test results shall be reported within the specified times established by the Reference Laboratories. Critical value test results shall be report immediately by telephone. Results will be sent via a secure interconnectivity line, in compliance with HIPPA guidelines. Electronic delivery of reports by computer interface is the normally required method of receipt. In those cases where electronic delivery is not possible, the Contractor shall deliver a hard copy of the report by hand, mail or facsimile. Delivery by electronic mail (e.g. Microsoft Outlook) is prohibited. If the electronic reporting requirements of this agreement are unavailable for use, the Contractor shall provide, without additional charge, expedited overnight courier shipping, mailing and/or transportation services to return printed copies of completed test results. Each test report shall include as a minimum: oPatients name and identification number (social security number) oProvider's name (if supplied) oTest Accession Number assigned by facility oFacility name oPatients location clinic/ward (if supplied) oDate/Time specimen received in reference lab oTest ordered oDate/Time of specimen collection (if available) oDate test completed oTest/diagnostic result oResults reported as consistent/inconsistent with prescribed medications oReference or reportable range oToxic/Therapeutic range (where applicable) oTesting laboratory specimen number oName, address and CLIA number of testing facility (contractor and/or subcontractor) oSpecimen validity (pH, presence of oxidizing agent, urine creatinine, temperature, specific gravity) oGC/LC/MS, or GC/MS, or LC/MS quantitative results for confirmation testing oNotation for result-specific presence of parent drug and metabolites oAny additional comments related to test provided by submitting labs oAny other information the laboratory has that may indicate questionable validity of test results (i.e., result inconsistent with human urine, adulteration) oUnsatisfactory specimen shall be reported with regard to its unsuitability for testing SUPPLIES: The Contractor shall provide all necessary supplies including, but not limited to the following: "Laboratory requisition forms that are united to the contracted reference library. "Special preservatives and packing material required for the collection, preservation, transportation capable of maintaining temperature requirements for specimens until they reach the Contractor's laboratory under the terms of this agreement "Special instructions "Current list of tests with reference ranges, specimen requirements, and test descriptions "Specimen carriers "Special media or special tubes for samples; all supplies for special tests "All forms necessary for specimens; Waiver consent forms for molecular/genetic test requests. "Specimen containers, pour off tubes, transport bags, shipping containers and dry ice that meet all requirements of state and federal regulatory requirements and accreditation agencies "Refrigerators "All color printers, fax machines and computer hardware, computer software, and replacement parts and maintenance (toner cartridges, etc.) to support the performance of the equipment required for test ordering, resulting and ongoing support "Required warning labels and mailing/shipping labels for all containers ("Contains Dry Ice", "Biohazardous", etc.) that meet international Air Transport Association and Code of Federal Regulation Title 49 Primary Urine Drug Screen (UDS) panel: To include the following drugs/drug classes, associated metabolites, with automatic reflex of positive (+) immunoassays of facility-designated drugs, for confirmation testing (LC/GC/MS or variation) to include the following: oAlcohol Metabolites (EtG/EtS) oAmphetamines (amphetamine; methamphetamine) oBarbiturates (butalbital; pentobarbital; phenobarbital; secobarbital/amobarbital) oBenzodiazepines (alprazolam, midazolam, clonazepam, lorazepam, diazepam, temazepam, oxazepam) oCocaine Metabolite oHeroin Metabolite (6-monoacetylmorphine; 6-MAM) oMarijuana Metabolite oMethadone Metabolite oOpiates (codeine, morphine, hydrocodone, hydromorphone) oOxycodone/oxymorphone oPhencyclidine (PCP) Panel is subject to change based upon patient population. (Optional add-on to primary UDS panel) Single, comprehensive, qualitative (LC/GC/MS or variation) urine test that can detect common drugs-of-abuse/prescription drugs, and pertinent metabolites, not included in a standard medical UDS, as well as important mental health/pain management adjuvants to include, but not limited to: oAmitriptyline oCarisoprodol oCarbamazepine oChlorpromazine oCitalopram oCotinine oCyclobenzaprine oDesipramine oDextromethorphan oDiltiazem oDoxepin oDuloxetine oFentanyl (and norfentanyl) oFluoxetine oGabapentin oHydroxyzine oIbuprofen oImipramine oKetamine oLamotrigine oLidocaine oMethocarbamol oMethylphenidate oMetoprolol oMidazolam oMirtazapine oNaproxen oNortriptyline oO-Desmethylvenlafaxine oOlanzapine oOxcarbazepine oParoxetine oPhenobarbital oPhentermine oPregabalin oPropranolol oQuetiapine oRisperidone oSertraline oTapentadol oTopiramate oTramadol oTrazodone oVenlafaxine oVerapamil oZolpidem (Optional add-on to primary UDS panel): buprenorphine immunoassay (preliminary screen, NOT confirmation testing). CONTRACTOR LABORATORY TECHNICIANS/PROCESSORS: Contractor will provide laboratory technicians/processors to accommodate the need of the Dorn VA Medical Center and the Community-Based Outpatient Clinics (CBOCs). POTENTIAL SOURCES SHALL PROVIDE THE FOLLOWING INFORMATION IN THEIR RESPONSE: 1)Company name, address, phone number, primary contact(s), e-mail address, NAICS code(s), business size (i.e., small/large) and DUNS Number. 2) Provide a Statement of Capability that demonstrates the offeror's past performance in providing this type of service. Please include the following: (a) staff expertise including their availability, experience, and formal and other training; (b) current in-house capability and capacity to perform the work; (c) prior completed projects of similar nature; (d) corporate experience and management capability; and (e) examples of prior completed Government contracts, references, and other related information. 3) Submit Capability Statements by September 13, 2016 to: Department of Veterans Affairs, Network Contracting Office, 501 Greene St, Hatcher Building, Suite 2, ATTN: Shirley Adams, Augusta, GA 30901-4401. Responses should be received no later than 2:00 PM EDT. Submissions must be made via email to: Shirley.Adams@va.gov NO CAPABILITY STATEMENTS MAY BE SUBMITTED AFTER September 13, 2016. AT THIS TIME NO SOLICITATION EXISTS. (DO NOT REQUEST A COPY OF THE SOLICITATION). A FUTURE NOTICE WILL BE POSTED WHEN THE SOLICITATION WILL BE RELEASED. 4) Disclaimer and Important Notes: This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a pre-solicitation synopsis and solicitation may be published in Federal Business Opportunities. However, responses to this notice will not be considered adequate responses to a solicitation. (5) No Proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s.)
 

Web Link

FBO.gov Permalink
(https://www.fbo.gov/spg/VA/AuVAMC/VAMCCO80220/VA24716Q0676/listing.html)
 

Document(s)

Attachment
 

File Name: VA247-16-Q-0676 VA247-16-Q-0676_3.docx (https://www.vendorportal.ecms.va.gov/FBODocumentServer/DocumentServer.aspx?DocumentId=2989048&FileName=VA247-16-Q-0676-000.docx)

Link: https://www.vendorportal.ecms.va.gov/FBODocumentServer/DocumentServer.aspx?DocumentId=2989048&FileName=VA247-16-Q-0676-000.docx

 

Note: If links are broken, refer to Point of Contact above or contact the FBO Help Desk at 877-472-3779.
 

Record

SN04257814-W 20160908/160907173649-8bcd6a773c8e848ba982fda863a677fa (fbodaily.com)
 

Source

FedBizOpps Link to This Notice
(may not be valid after Archive Date)

---

| FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |